MSInsight Closes €1.6M in Seed Funding to Advance AI-Powered Precision Medicine in Oncology March 11, 2025
ConcertAI to Acquire CancerLinQ to Build the Leading Healthcare Learning and Research Network in Oncology December 15, 2023
Phenomic Enters Strategic Collaboration with Boehringer Ingelheim to Discover Novel Targets for Stroma-Rich Cancer Therapies December 2, 2023
MSInsight Closes €1.6M in Seed Funding to Advance AI-Powered Precision Medicine in Oncology March 11, 2025
ConcertAI to Acquire CancerLinQ to Build the Leading Healthcare Learning and Research Network in Oncology December 15, 2023
Phenomic Enters Strategic Collaboration with Boehringer Ingelheim to Discover Novel Targets for Stroma-Rich Cancer Therapies December 2, 2023